about
Is There Any Scientific Basis of Hawan to be used in Epilepsy-Prevention/Cure?Absorption-Enhancing Effects of Bile SaltsRecent advances in protein and Peptide drug delivery: a special emphasis on polymeric nanoparticlesMitigating the looming vaccine crisis: production and delivery of plasmid-based vaccinesElectrophoretic particle guidance significantly enhances olfactory drug delivery: a feasibility studyPreparation and the influencing factors of timozolomide liposomes.Photoresponsive nanocapsulation of cobra neurotoxin and enhancement of its central analgesic effects under red light.Intranasal naltrexone and atipamezole for reversal of white-tailed deer immobilized with carfentanil and medetomidine.Clinical efficacy of a spray containing hyaluronic Acid and dexpanthenol after surgery in the nasal cavity (septoplasty, simple ethmoid sinus surgery, and turbinate surgery)Drug transporter expression and localization in rat nasal respiratory and olfactory mucosa and olfactory bulb.Development and characterization of mucoadhesive in situ nasal gel of midazolam prepared with Ficus carica mucilage.Preparation and efficacy of a live newcastle disease virus vaccine encapsulated in chitosan nanoparticles.Huperzine A activates Wnt/β-catenin signaling and enhances the nonamyloidogenic pathway in an Alzheimer transgenic mouse modelIntranasal delivery of plasma and platelet growth factors using PRGF-Endoret system enhances neurogenesis in a mouse model of Alzheimer's disease.Solid microparticles based on chitosan or methyl-β-cyclodextrin: a first formulative approach to increase the nose-to-brain transport of deferoxamine mesylateIntranasal delivery of Norwalk virus-like particles formulated in an in situ gelling, dry powder vaccine.Wheat germ agglutinin enhanced cerebral uptake of anti-Aβ antibody after intranasal administration in 5XFAD miceBrain Uptake of Neurotherapeutics after Intranasal versus Intraperitoneal Delivery in Mice.Assessment of C-phycocyanin effect on astrocytes-mediated neuroprotection against oxidative brain injury using 2D and 3D astrocyte tissue model.Delivery of parathyroid hormone for the treatment of osteoporosis.Factors of importance for a successful delivery system for proteins.Ayurvedic medicinal plants for Alzheimer's disease: a review.Nanosuspension based in situ gelling nasal spray of carvedilol: development, in vitro and in vivo characterization.Impact of Absorption and Transport on Intelligent Therapeutics and Nano-scale Delivery of Protein Therapeutic Agents.Therapeutic management of allergic diseases.The application of mucoadhesive polymers in nasal drug delivery.Chitosan-based hydrogels for nasal drug delivery: from inserts to nanoparticles.In vivo nucleic acid delivery with PEI and its derivatives: current status and perspectives.Nasal route: an alternative approach for antiemetic drug delivery.Nanocarrier possibilities for functional targeting of bioactive peptides and proteins: state-of-the-art.Physicochemical and physiological considerations for efficient nose-to-brain targeting.Leuprolide acetate: pharmaceutical use and delivery potentials.Application and use of Inulin as a tool for therapeutic drug delivery.Strategies for enhanced peptide and protein delivery.Drug transporters in the nasal epithelium: an overview of strategies in targeted drug delivery.Nanomedicine for the treatment of Alzheimer's disease.Is RPMI 2650 a Suitable In Vitro Nasal Model for Drug Transport Studies?Challenges in nasal drug absorption: how far have we come?Emerging delivery platforms for mucosal administration of biopharmaceuticals: a critical update on nasal, pulmonary and oral routes.Hydrogel nanoparticles and nanocomposites for nasal drug/vaccine delivery.
P2860
Q26773075-DFEA3264-E949-42FE-814F-FBD064074B5FQ26798510-6D0CB839-A202-4B7A-9938-9E2CCA47C62AQ27028129-B20F6C2F-E856-4395-8F50-A19E8A3A970EQ28294355-AA2B1C35-FC95-4B91-B239-90178B4D9156Q28539362-389519F1-D96C-47C2-BDB3-3FDC4931FA8FQ33515630-60D3D9F0-2241-40F1-ADBC-E2DD34246D4FQ33650533-DD26F1A3-23B4-459D-B181-9D36AD4FD45FQ33801355-F64E5A90-5CFF-4A40-B8AF-9843FE54DB43Q33930494-9F4F61C6-E109-488E-952D-9A8C25A912BDQ34211080-22F495C5-FAFE-46FE-81CD-DADAEB38EE2BQ34280244-DC6EFF49-7384-4ED3-B899-37BA74C6E275Q34535130-969D8BE9-3368-4D18-902B-DBB62AC81A00Q34797526-2368B3E5-B8F5-477B-9789-CC372A1836F4Q34998572-4D55B1A8-B04F-4650-9CAA-72C6AE5E8C0BQ35088391-D48DEE89-4E9A-49C2-8937-5E5EF91FB5F1Q35112676-DB258B66-BC57-4553-B54F-7A86C8574802Q35300928-5A660D87-1386-4D75-946B-385C13816756Q36052412-A8007E93-55C8-4009-AE04-1BF2743936DDQ36099651-E1AA7BB7-1B66-4BF1-A024-AC6586AB2B1BQ36316910-CAADF1E4-1C83-4DB2-A951-C762B24046F0Q36316926-E7CE3729-857E-4B7D-8762-4E0B0C16B9F4Q36424824-7012903B-241B-48D2-9DD1-EA32045B6477Q36636492-AEB90021-4146-4D9B-9B37-5CB9639E11CFQ37436438-C094F81D-EC3D-41EC-BDEE-8BAC7959C921Q37550543-5026B03F-1E1A-4F19-AD34-D8F80758CA2DQ37593083-E255C522-8867-42AB-8DA6-75899892A6A7Q37766235-27F1FDDF-F079-42B0-A860-E0EBFFC28875Q37850449-EBFC5DF6-3D2D-4E2D-9620-0666573FAF9AQ37946545-834D7652-156B-4A1F-9F7A-D55E4A35C257Q37948968-3A8A6CCD-45DF-4D65-AC5A-381D90B4AA04Q37968642-049696B3-5E97-444E-AD16-151622500D71Q37984084-6304605C-9737-407E-83B8-CDDD0FD32FCFQ38012147-74A7FDAA-9A2D-4484-A927-A59A464DB70BQ38104408-13543083-12F4-4245-A9F9-47E722619980Q38261366-C38BFB57-8852-464B-80C1-41C11380F2ADQ38451932-FF3EB436-9BFE-462D-A417-76E6BDCBFF54Q38688723-22D45C8B-AA49-47CB-86EA-C3B3A9230624Q38842805-8A86B063-6652-421F-8FCA-D853BB7C75DCQ38847705-CA62F3E2-EDC8-453B-97D4-C215930A1BEDQ38879581-26AAD4EA-BB6C-4C02-A200-35DAC613B64D
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Nasal route and drug delivery systems.
@ast
Nasal route and drug delivery systems.
@en
type
label
Nasal route and drug delivery systems.
@ast
Nasal route and drug delivery systems.
@en
prefLabel
Nasal route and drug delivery systems.
@ast
Nasal route and drug delivery systems.
@en
P2093
P1476
Nasal route and drug delivery systems.
@en
P2093
Erten Onur
Selcan Türker
Yekta Ozer
P304
P356
10.1023/B:PHAR.0000026823.82950.FF
P407
P577
2004-06-01T00:00:00Z